You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Drug Price Trends for PREDNISOLONE ODT


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for PREDNISOLONE ODT

Average Pharmacy Cost for PREDNISOLONE ODT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PREDNISOLONE ODT 10 MG TABLET 66993-0844-51 6.83983 EACH 2024-07-17
PREDNISOLONE ODT 10 MG TABLET 66993-0844-35 6.83983 EACH 2024-07-17
PREDNISOLONE ODT 10 MG TABLET 66993-0844-35 7.57333 EACH 2024-06-19
PREDNISOLONE ODT 10 MG TABLET 66993-0844-51 7.57333 EACH 2024-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Prednisolone ODT

Introduction to Prednisolone ODT

Prednisolone ODT (orally disintegrating tablets) is a formulation of the synthetic glucocorticoid prednisolone, widely used for its anti-inflammatory and immunosuppressive properties. It is prescribed for various conditions, including asthma, allergies, autoimmune disorders, and other inflammatory diseases[1][4].

Market Significance and Growth Drivers

The prednisolone market, including the ODT formulation, is a significant segment of the pharmaceutical industry. Here are some key drivers of its growth:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as asthma, allergies, and autoimmune disorders is a primary driver of the prednisolone market. These conditions are becoming more prevalent globally, necessitating effective treatment options[1].

Advancements in Drug Formulations

Recent innovations in drug formulations, including extended-release and combination therapies, are enhancing the efficacy of prednisolone. The introduction of orally disintegrating tablets (ODT) has improved patient compliance and therapeutic outcomes, making them more attractive to both healthcare providers and patients[1].

Greater Awareness and Access to Healthcare

Increased awareness about the benefits of prednisolone and improved access to healthcare facilities are contributing to the market's expansion. Patients are seeking more effective treatments for chronic conditions, leading to a higher demand for prednisolone prescriptions[1].

Market Size and Projection

The global prednisolone market is projected to achieve significant growth in the coming years. Here are some key projections:

Global Market Size

The prednisolone market is expected to reach substantial value by 2027, driven by the increasing prevalence of chronic diseases and advancements in pharmaceutical research[1].

Regional Market Analysis

  • North America: This region is expected to hold a significant share of the market, driven by the rising prevalence of asthma and other chronic conditions. Asthma affects approximately 7% of Americans, contributing to the high demand for prednisolone[3].
  • Asia Pacific: The APAC region is also anticipated to experience notable growth due to the increasing prevalence of diseases such as chronic kidney disease and the lack of physical activity in this region[3].

Price Analysis for Prednisolone ODT

The pricing of prednisolone ODT can vary based on several factors, including the dosage, quantity, and pharmacy.

Current Pricing

  • Orapred ODT 10 mg: The cost for Orapred ODT 10 mg oral tablet, disintegrating, is around $311 for a supply of 12 tablets. However, generic versions are available at a lower price, starting from $107.59 for 12 tablets[2][5].

Price Variability

Prices can vary significantly depending on the pharmacy and the availability of generic versions. Here are some examples:

  • Generic 10 mg ODT: $107.59 for 12 tablets[5].
  • Generic 15 mg ODT: $195.61 for 12 tablets[5].

Factors Influencing Pricing

  • Pharmacy Discounts: Prices can be lower with discount cards and coupons.
  • Generic Availability: Generic versions of prednisolone ODT are generally cheaper than brand-name versions.
  • Stock Shortages: Prices may fluctuate due to stock shortages and other market variables[2][5].

Strategic Developments and Innovations

New Product Launches

Pharmaceutical companies are continually introducing new formulations of prednisolone to cater to diverse patient needs. For example, BioMarin's Orapred ODT, an orally disintegrating tablet, was introduced to provide a convenient and easy-to-administer formulation of prednisolone[4].

Strategic Partnerships

Strategic partnerships between pharmaceutical companies and research institutions are fostering innovation in the prednisolone market. These collaborations aim to develop more effective and targeted therapies, further solidifying prednisolone's position in the pharmaceutical landscape[1].

Mergers and Acquisitions

The prednisolone market has seen a rise in mergers and acquisitions, allowing companies to consolidate resources and expand their market presence. This trend is expected to continue as businesses seek to enhance their product offerings and improve operational efficiencies[1].

Future Outlook

The future of the prednisolone market, including the ODT formulation, appears promising. Here are some key factors that will shape the market:

Ongoing Research and Technological Advancements

Continuous research and technological advancements are expected to drive the market forward. Innovations in drug delivery systems and personalized medicine will play a crucial role in shaping the market landscape[1].

Increasing Demand for Effective Treatments

As healthcare providers strive for better treatment outcomes, the demand for prednisolone is anticipated to rise. The growing prevalence of chronic diseases and the need for effective treatments will continue to drive the market growth[1].

Key Takeaways

  • Growing Market: The prednisolone market is driven by the increasing prevalence of chronic diseases and advancements in pharmaceutical research.
  • Price Variability: Prices for prednisolone ODT vary based on dosage, quantity, and pharmacy, with generic versions generally being cheaper.
  • Innovations: New product launches, strategic partnerships, and mergers and acquisitions are key factors in the market's growth.
  • Future Outlook: The market is expected to continue growing due to ongoing research, technological advancements, and increasing demand for effective treatments.

FAQs

What is prednisolone ODT used for?

Prednisolone ODT is used to treat various conditions, including asthma, allergies, autoimmune disorders, and other inflammatory diseases due to its anti-inflammatory and immunosuppressive properties[1].

How much does prednisolone ODT cost?

The cost of prednisolone ODT can range from around $107.59 for a generic 10 mg formulation to $311 for a brand-name 10 mg formulation for a supply of 12 tablets[2][5].

What are the common side effects of prednisolone ODT?

Common side effects may include weight gain, increased appetite, and mood changes. Long-term use can lead to more serious complications[1].

Why is the demand for prednisolone ODT increasing?

The demand is increasing due to the rising prevalence of chronic diseases such as asthma, allergies, and autoimmune disorders, as well as advancements in drug formulations and greater awareness among patients[1].

Are there any new developments in the prednisolone market?

Yes, there are ongoing innovations, including new product launches, strategic partnerships, and mergers and acquisitions, which are driving the market forward[1][4].

Sources

  1. Market Research Intellect: "Prednisolone Market Size And Projection - Market Research Intellect"
  2. Drugs.com: "Orapred ODT Prices, Coupons, Copay Cards & Patient Assistance"
  3. Research Nester: "Prednisone Market Size & Share, Growth Forecasts 2036"
  4. BioMarin: "BioMarin Files New Drug Application for Orapred ODT"
  5. Drugs.com: "Prednisolone Prices, Coupons, Copay Cards & Patient Assistance"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.